Treatment with XBP1 silencing had no significant difference on heart size and myocyte size (Fig. 2B–C); however, XBP1‐silenced mice exacerbated cardiac hypertrophy after ISO infusion as evidenced by ANP mRNA expression and interstitial fibrosis (Fig. 2D–E). The gene discussed is NPPA; the disease is cardiac hypertrophy.